Gaudium IVF & Women Health IPO: Check GMP, Key Highlights & Important Details
If you are tracking the Gaudium IVF & Women Health IPO, this guide covers everything you need – including IPO overview, price band, lot size, key dates, Grey Market Premium (GMP), company profile, financial highlights, risks, and investment outlook.
Gaudium IVF & Women Health Limited operates in the fertility and women’s healthcare segment. With rising demand for IVF and assisted reproductive services in India, this SME IPO has attracted attention from healthcare-focused investors.
Gaudium IVF & Women Health IPO Overview
| Attribute | Details |
|---|---|
| Company Name | Gaudium IVF & Women Health Limited |
| IPO Type | SME IPO (Book Built Issue) |
| Total Issue Size | ₹48.00 crore (Approx) |
| Fresh Issue | ₹48.00 crore |
| Offer for Sale (OFS) | Nil |
| Price Band | ₹40 – ₹42 per share |
| Face Value | ₹10 per share |
| Lot Size | 3,000 shares |
| Minimum Investment | ₹1,26,000 (3,000 × ₹42) |
| IPO Open Date | February 24, 2026 |
| IPO Close Date | February 27, 2026 |
| Allotment Date (Tentative) | February 28, 2026 |
| Expected Listing Date | March 3, 2026 |
| Listing Exchange | NSE SME |
| Registrar | Skyline Financial Services Pvt Ltd |
Gaudium IVF IPO GMP (Grey Market Premium)
| GMP Indicator | Value |
|---|---|
| Latest GMP | ₹5 per share |
| Estimated Listing Price | ~₹47 |
| Estimated Listing Gain | ~11–12% |
What GMP Indicates
- Current GMP suggests positive early sentiment.
- It indicates possible listing gains if demand sustains.
- GMP is unofficial and can change daily.
Always combine GMP with company fundamentals before investing.
About Gaudium IVF & Women Health
Gaudium IVF & Women Health Limited provides fertility and reproductive healthcare services.
Key Services:
- IVF (In Vitro Fertilization)
- IUI treatments
- Fertility preservation
- Gynecology services
- Diagnostic and women health services
The company focuses on specialized reproductive healthcare and operates in a high-growth medical segment.
Financial Highlights
Before investing, review:
- Revenue growth trend
- Profit margins
- Expansion plans
- Return ratios
- Operational efficiency
IVF clinics depend heavily on brand reputation, doctor expertise, and successful treatment outcomes.
Key Strengths
- Growing IVF and fertility demand in India
- Specialized healthcare positioning
- Rising awareness of assisted reproductive technology
- SME scale with expansion potential
Key Risks
- SME IPO volatility
- Dependence on specialist doctors
- Regulatory oversight in ART sector
- High competition in metro cities
- Limited liquidity after listing
Should You Apply?
Consider applying if:
- You are comfortable with SME IPO risks
- You seek exposure to fertility and women healthcare
- You understand the liquidity risks of SME listings
Key Takeaways
- Issue Size: ₹48 crore
- Price Band: ₹40–₹42
- Lot Size: 3,000 shares
- Minimum Investment: ₹1,26,000
- GMP: ₹5
- Listing: NSE SME
Gaudium IVF IPO provides exposure to India’s growing fertility healthcare sector, but investors should assess SME-related risks carefully.
FAQs – Gaudium IVF IPO
Q. What is the GMP of Gaudium IVF IPO today?
The latest reported GMP is ₹5 per share. It may change daily based on market sentiment.
Q. What is the minimum investment required in Gaudium IVF IPO?
The minimum investment is ₹1,26,000 for 1 lot (3,000 shares at ₹42).
Q. Is Gaudium IVF IPO a mainboard IPO?
No, it is an SME IPO and will be listed on the NSE SME platform.
Q. Is Gaudium IVF IPO risky?
Yes, SME IPOs carry higher volatility and lower liquidity compared to mainboard IPOs.
Q. When is Gaudium IVF IPO listing date?
The expected listing date is March 3, 2026.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.
